New Journey Health Technology Group Co.,LTD (SHE:002219)

SHE:002219 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	3,100	3,789	3,903	3,153	3,007	2,794
Other Revenue	9.78	9.78	11.19	8.13	8.79	12.13
Revenue	3,110	3,799	3,914	3,161	3,016	2,806
Revenue Growth (YoY)	-28.55%	-2.94%	23.83%	4.80%	7.49%	-23.84%
Cost of Revenue	2,172	2,623	2,742	2,169	2,209	2,016
Gross Profit	938.09	1,176	1,173	992.42	807.44	790.33
Selling, General & Admin	639.06	805.16	874.74	690.55	717.15	557.05
Research & Development	14.5	9.86	27.71	0.24	0.44	0.3
Other Operating Expenses	28.27	22.44	21.17	17.92	20.38	13.94
Operating Expenses	714.95	869.21	995.87	762.51	843	611.06
Operating Income	223.14	307.21	176.87	229.91	-35.56	179.27
Interest Expense	-131.01	-135.03	-128.48	-142.62	-230.03	-136.61
Interest & Investment Income	7.95	13.79	28.97	59.64	26.63	105.32
Currency Exchange Gain (Loss)	-	-	-	0	-	-0.3
Other Non Operating Income (Expenses)	-25.22	-32.81	-68.39	40.43	-17.08	-5.64
EBT Excluding Unusual Items	74.86	153.16	8.97	187.36	-256.03	142.03
Impairment of Goodwill	-	-	-	-	-102.59	-
Gain (Loss) on Sale of Investments	-0.49	0.01	-	-	-	-0.19
Gain (Loss) on Sale of Assets	-0.48	-0.07	-0.19	-0.17	-0.67	-4.84
Asset Writedown	-1.66	-1.19	-3.38	-1.67	-17.12	-4.43
Legal Settlements	-	-	-	-0.39	-0.3	-3.79
Other Unusual Items	-3.66	2.33	5.69	2.47	14.33	-118.79
Pretax Income	68.58	154.23	11.09	187.59	-362.39	9.99
Income Tax Expense	51.76	33.9	-28.77	22.71	4.91	52.5
Earnings From Continuing Operations	16.82	120.33	39.86	164.89	-367.3	-42.51
Minority Interest in Earnings	2.76	-5.56	-10.89	-8.77	-4.13	-9.73
Net Income	19.58	114.77	28.97	156.12	-371.43	-52.24
Net Income to Common	19.58	114.77	28.97	156.12	-371.43	-52.24
Net Income Growth	-62.54%	296.13%	-81.44%	-	-	-
Shares Outstanding (Basic)	3,257	3,288	3,255	3,266	1,866	1,866
Shares Outstanding (Diluted)	3,257	3,288	3,255	3,266	1,866	1,866
Shares Change (YoY)	-1.65%	1.02%	-0.33%	75.08%	-0.02%	-0.03%
EPS (Basic)	0.01	0.03	0.01	0.05	-0.20	-0.03
EPS (Diluted)	0.01	0.03	0.01	0.05	-0.20	-0.03
EPS Growth	-61.91%	292.13%	-81.38%	-	-	-
Free Cash Flow	91.95	131.06	111.25	46.47	78.56	67.23
Free Cash Flow Per Share	0.03	0.04	0.03	0.01	0.04	0.04
Gross Margin	30.17%	30.97%	29.96%	31.40%	26.77%	28.17%
Operating Margin	7.17%	8.09%	4.52%	7.27%	-1.18%	6.39%
Profit Margin	0.63%	3.02%	0.74%	4.94%	-12.31%	-1.86%
Free Cash Flow Margin	2.96%	3.45%	2.84%	1.47%	2.60%	2.40%
EBITDA	346.8	466.94	384.69	385.85	127.28	349.92
EBITDA Margin	11.15%	12.29%	9.83%	12.21%	4.22%	12.47%
D&A For EBITDA	123.66	159.73	207.82	155.94	162.84	170.65
EBIT	223.14	307.21	176.87	229.91	-35.56	179.27
EBIT Margin	7.17%	8.09%	4.52%	7.27%	-1.18%	6.39%
Effective Tax Rate	75.48%	21.98%	-	12.10%	-	525.52%
Revenue as Reported	3,110	3,799	3,914	3,161	3,016	2,806
Advertising Expenses	-	265.25	187.86	71.92	58.15	51.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.